$ Value
$0
Shares
33
Price
$0
Filed
Sep 16
Insider
Name
Yocca Frank
Title
Chief Scientific Officer
CIK
0001733272
Roles
Transaction Details
Transaction Date
2025-09-14
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
163
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | On March 14, 2022, the Reporting Person was granted 521 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. | On March 15, 2023, the Reporting Person was granted 562 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Filing Info
Yocca Frank's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-15 | BTAI | M | — |
| 2026-03-15 | BTAI | M | $0 |
| 2026-03-14 | BTAI | M | — |
| 2026-03-14 | BTAI | M | $0 |
| 2026-01-01 | BTAI | A | $0 |
| 2025-12-15 | BTAI | M | — |
| 2025-12-15 | BTAI | M | $0 |
| 2025-12-14 | BTAI | M | — |
| 2025-12-14 | BTAI | M | $0 |
| 2025-09-15 | BTAI | M | — |
Other Insiders at BTAI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Steinhart Richard I
Chief Financial Officer
|
— | — | 2026-03-15 |
|
Yocca Frank
Chief Scientific Officer
|
— | — | 2026-03-15 |
|
Mehta Vimal
CEO and President
|
— | — | 2026-03-15 |
|
Rodriguez Javier
See Remarks
|
— | — | 2026-03-15 |